Portunus trituberculatus isolate SZX2019 chromosome 35, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030105.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC123513236, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123513236, transcript variant X5
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC123513236, transcript variant X3
uncharacterized LOC123513236, transcript variant X2
uncharacterized LOC123513236, transcript variant X6
uncharacterized LOC123513236, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
low molecular weight phosphotyrosine protein phosphatase-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: low molecular weight phosphotyrosine protein phosphatase-like
uncharacterized LOC123513162, transcript variant X2
uncharacterized LOC123513162, transcript variant X1
uncharacterized protein LOC123513162 isoform X2
uncharacterized protein LOC123513162 isoform X1
thymosin beta-like, transcript variant X3
thymosin beta-like, transcript variant X4
thymosin beta-like, transcript variant X1
thymosin beta-like, transcript variant X7
thymosin beta-like, transcript variant X6
thymosin beta-like, transcript variant X8
thymosin beta-like, transcript variant X5
thymosin beta-like, transcript variant X9
thymosin beta-like, transcript variant X2
uncharacterized protein LOC123513166 isoform X1
uncharacterized protein LOC123513166 isoform X3
uncharacterized protein LOC123513166 isoform X2
uncharacterized protein LOC123513166 isoform X4
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X1
insulin-like growth factor-binding protein complex acid labile subunit, transcript variant X2
insulin-like growth factor-binding protein complex acid labile subunit
mitochondrial carnitine/acylcarnitine carrier protein-like, transcript variant X1
mitochondrial carnitine/acylcarnitine carrier protein-like isoform X1
mitochondrial carnitine/acylcarnitine carrier protein-like, transcript variant X2
mitochondrial carnitine/acylcarnitine carrier protein-like isoform X2
uncharacterized LOC123513168, transcript variant X2
uncharacterized LOC123513168, transcript variant X1
uncharacterized LOC123513168, transcript variant X4
uncharacterized LOC123513168, transcript variant X3
uncharacterized protein LOC123513168 isoform X2
uncharacterized protein LOC123513168 isoform X1
uncharacterized protein LOC123513168 isoform X3
multiple PDZ domain protein-like, transcript variant X1
multiple PDZ domain protein-like, transcript variant X2
multiple PDZ domain protein-like isoform X2
multiple PDZ domain protein-like isoform X1
uncharacterized LOC123513005, transcript variant X2
uncharacterized LOC123513005, transcript variant X1
uncharacterized LOC123513002, transcript variant X2
uncharacterized LOC123513002, transcript variant X1
transmembrane protein 107-like, transcript variant X3
transmembrane protein 107-like, transcript variant X2
transmembrane protein 107-like, transcript variant X1
thioredoxin domain-containing protein 17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
serine--tRNA synthetase-like protein Slimp
LOW QUALITY PROTEIN: NKAP family protein CG6066-like
thymidylate kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
thymidylate kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
2',3'-cyclic-nucleotide 3'-phosphodiesterase-like
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
histone PARylation factor 1-like, transcript variant X4
histone PARylation factor 1-like, transcript variant X3
histone PARylation factor 1-like, transcript variant X2
histone PARylation factor 1-like, transcript variant X1
histone PARylation factor 1-like isoform X3
histone PARylation factor 1-like isoform X4
histone PARylation factor 1-like isoform X2
histone PARylation factor 1-like isoform X1
LOW QUALITY PROTEIN: uncharacterized protein LOC123513016
apoptosis-inducing factor 3-like, transcript variant X4
apoptosis-inducing factor 3-like, transcript variant X1
apoptosis-inducing factor 3-like isoform X1
apoptosis-inducing factor 3-like, transcript variant X2
apoptosis-inducing factor 3-like, transcript variant X3
apoptosis-inducing factor 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
ribonucleoside-diphosphate reductase subunit M2-like
LOW QUALITY PROTEIN: ragulator complex protein LAMTOR4-like
LOW QUALITY PROTEIN: transducin beta-like protein 3
uncharacterized LOC123513171, transcript variant X2
uncharacterized LOC123513171, transcript variant X4
uncharacterized LOC123513171, transcript variant X3
uncharacterized LOC123513171, transcript variant X1
uncharacterized LOC123513171, transcript variant X5
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized protein K02A2.6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein K02A2.6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein K02A2.6-like isoform X1
uncharacterized protein K02A2.6-like isoform X2
sodium-dependent dopamine transporter-like, transcript variant X3
sodium-dependent dopamine transporter-like, transcript variant X1
sodium-dependent dopamine transporter-like, transcript variant X2
sodium-dependent dopamine transporter-like
phospholipid phosphatase-related protein type 2-like
endochitinase A-like, transcript variant X1
endochitinase A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
endochitinase A-like, transcript variant X2
uncharacterized protein LOC123512946 isoform X1
uncharacterized protein LOC123512946 isoform X2
KIF-binding protein-like, transcript variant X8
KIF-binding protein-like, transcript variant X4
KIF-binding protein-like, transcript variant X5
KIF-binding protein-like, transcript variant X1
KIF-binding protein-like, transcript variant X2
KIF-binding protein-like, transcript variant X6
KIF-binding protein-like, transcript variant X3
KIF-binding protein-like, transcript variant X7
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123512973
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
cytochrome c oxidase assembly factor 6 homolog, transcript variant X2
cytochrome c oxidase assembly factor 6 homolog, transcript variant X3
cytochrome c oxidase assembly factor 6 homolog isoform X2
cytochrome c oxidase assembly factor 6 homolog, transcript variant X4
cytochrome c oxidase assembly factor 6 homolog, transcript variant X1
cytochrome c oxidase assembly factor 6 homolog isoform X1
cytochrome c oxidase assembly factor 6 homolog isoform X4
cytochrome c oxidase assembly factor 6 homolog isoform X3
protein abrupt-like, transcript variant X3
protein abrupt-like, transcript variant X1
protein abrupt-like, transcript variant X2
zinc finger and BTB domain-containing protein 14-like isoform X1
synaptotagmin-1-like, transcript variant X2
synaptotagmin-1-like, transcript variant X1
transient receptor potential protein-like, transcript variant X3
transient receptor potential protein-like, transcript variant X1
transient receptor potential protein-like, transcript variant X2
transient receptor potential protein-like isoform X1
transient receptor potential protein-like isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dorsal root ganglia homeobox protein-like
LOW QUALITY PROTEIN: uncharacterized protein LOC123512948
F-box/WD repeat-containing protein 2-like
protein tyrosine phosphatase type IVA 2-like, transcript variant X3
protein tyrosine phosphatase type IVA 2-like, transcript variant X1
protein tyrosine phosphatase type IVA 2-like, transcript variant X2
protein tyrosine phosphatase type IVA 2-like, transcript variant X4
protein tyrosine phosphatase type IVA 2-like
sperm mitochondrial-associated cysteine-rich protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
nuclear hormone receptor FTZ-F1 beta-like, transcript variant X3
nuclear hormone receptor FTZ-F1 beta-like, transcript variant X1
nuclear hormone receptor FTZ-F1 beta-like, transcript variant X2
nuclear hormone receptor FTZ-F1 beta-like isoform X2
nuclear hormone receptor FTZ-F1 beta-like isoform X1
uncharacterized LOC123513093, transcript variant X3
uncharacterized LOC123513093, transcript variant X4
uncharacterized LOC123513093, transcript variant X5
uncharacterized LOC123513093, transcript variant X6
uncharacterized LOC123513093, transcript variant X1
uncharacterized LOC123513093, transcript variant X2
uncharacterized protein LOC123513093 isoform X4
uncharacterized protein LOC123513093 isoform X2
uncharacterized protein LOC123513093 isoform X3
uncharacterized protein LOC123513093 isoform X1
phosphatidylinositol 3-kinase catalytic subunit type 3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein SDA1 homolog
CLOCK-interacting pacemaker-like, transcript variant X1
CLOCK-interacting pacemaker-like, transcript variant X2
transcription factor GTE2-like isoform X2
CLOCK-interacting pacemaker-like isoform X1
uncharacterized LOC123513241, transcript variant X1
uncharacterized LOC123513241, transcript variant X2
mechanosensory protein 2-like, transcript variant X8
mechanosensory protein 2-like, transcript variant X9
mechanosensory protein 2-like, transcript variant X3
mechanosensory protein 2-like, transcript variant X1
mechanosensory protein 2-like, transcript variant X4
mechanosensory protein 2-like, transcript variant X2
band 7 protein AGAP004871-like isoform X8
band 7 protein AGAP004871-like isoform X9
band 7 protein AGAP004871-like isoform X3
band 7 protein AGAP004871-like isoform X1
band 7 protein AGAP004871-like isoform X4
band 7 protein AGAP004871-like isoform X2
mechanosensory protein 2-like, transcript variant X6
band 7 protein AGAP004871-like isoform X6
mechanosensory protein 2-like, transcript variant X7
band 7 protein AGAP004871-like isoform X7
mechanosensory protein 2-like, transcript variant X10
mechanosensory protein 2-like, transcript variant X11
mechanosensory protein 2-like, transcript variant X14
band 7 protein AGAP004871-like isoform X10
band 7 protein AGAP004871-like isoform X11
mechanosensory protein 2-like isoform X14
mechanosensory protein 2-like, transcript variant X5
mechanosensory protein 2-like, transcript variant X13
band 7 protein AGAP004871-like isoform X5
band 7 protein AGAP004871-like isoform X13
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
mechanosensory protein 2-like, transcript variant X16
mechanosensory protein 2-like, transcript variant X15
mechanosensory protein 2-like, transcript variant X12
band 7 protein AGAP004871-like isoform X12
mechanosensory protein 2-like isoform X16
band 7 protein AGAP004871-like isoform X15
TBC1 domain family member 7-like, transcript variant X1
TBC1 domain family member 7-like, transcript variant X2
TBC1 domain family member 7-like, transcript variant X3
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123513343, transcript variant X3
uncharacterized LOC123513343, transcript variant X4
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like, transcript variant X1
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like, transcript variant X2
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like
uncharacterized LOC123513343, transcript variant X2
uncharacterized LOC123513343, transcript variant X1
uncharacterized LOC123513343, transcript variant X5
uncharacterized LOC123513344, transcript variant X1
uncharacterized LOC123513344, transcript variant X2
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger protein 569-like, transcript variant X1
zinc finger protein 569-like, transcript variant X2
zinc finger protein 569-like, transcript variant X3
structural maintenance of chromosomes protein 1A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X8
protein tramtrack, beta isoform-like isoform X8
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X4
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X7
protein tramtrack, beta isoform-like isoform X7
protein tramtrack, beta isoform-like isoform X4
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tramtrack, beta isoform-like isoform X2
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tramtrack, beta isoform-like isoform X10
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X6
protein tramtrack, beta isoform-like isoform X6
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tramtrack, beta isoform-like isoform X3
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X11
protein tramtrack, beta isoform-like isoform X11
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
longitudinals lacking protein, isoforms A/B/D/L-like isoform X13
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X16
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X18
protein tramtrack, beta isoform-like isoform X16
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X5
protein tramtrack, beta isoform-like isoform X5
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X12
protein tramtrack, beta isoform-like isoform X12
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X17
longitudinals lacking protein, isoforms A/B/D/L-like isoform X15
longitudinals lacking protein, isoforms A/B/D/L-like, transcript variant X9
protein tramtrack, beta isoform-like isoform X9
eukaryotic translation initiation factor 4 gamma 1-like, transcript variant X1
eukaryotic translation initiation factor 4 gamma 1-like, transcript variant X2
eukaryotic translation initiation factor 4 gamma 1-like
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
zinc finger SWIM domain-containing protein 4-like
bestrophin-3-like, transcript variant X6
bestrophin-3-like, transcript variant X3
bestrophin-3-like, transcript variant X4
bestrophin-3-like, transcript variant X1
bestrophin-3-like, transcript variant X9
bestrophin-3-like, transcript variant X10
bestrophin-3-like, transcript variant X8
bestrophin-3-like, transcript variant X7
bestrophin-3-like, transcript variant X5
bestrophin-3-like, transcript variant X2
uncharacterized LOC123512930, transcript variant X2
uncharacterized LOC123512930, transcript variant X1
uncharacterized LOC123512930, transcript variant X3
uncharacterized LOC123512930, transcript variant X4
putative nuclease HARBI1, transcript variant X2
putative nuclease HARBI1, transcript variant X1
uncharacterized LOC123512935, transcript variant X3
uncharacterized LOC123512935, transcript variant X2
uncharacterized LOC123512935, transcript variant X1
uncharacterized protein LOC123512935 isoform X1
uncharacterized protein LOC123512935 isoform X2
band 7 protein AGAP004871-like, transcript variant X16
band 7 protein AGAP004871-like, transcript variant X8
band 7 protein AGAP004871-like, transcript variant X7
band 7 protein AGAP004871-like, transcript variant X2
band 7 protein AGAP004871-like, transcript variant X5
band 7 protein AGAP004871-like, transcript variant X4
band 7 protein AGAP004871-like, transcript variant X3
band 7 protein AGAP004871-like, transcript variant X1
band 7 protein AGAP004871-like, transcript variant X6
band 7 protein AGAP004871-like, transcript variant X14
band 7 protein AGAP004871-like, transcript variant X15
band 7 protein AGAP004871-like, transcript variant X13
band 7 protein AGAP004871-like isoform X14
band 7 protein AGAP004871-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
band 7 protein AGAP004871-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
band 7 protein AGAP004871-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
band 7 protein AGAP004871-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123512937, transcript variant X3
uncharacterized LOC123512937, transcript variant X5
uncharacterized LOC123512937, transcript variant X1
uncharacterized LOC123512937, transcript variant X2
uncharacterized LOC123512937, transcript variant X4
uncharacterized protein LOC123512937 isoform X2
uncharacterized protein LOC123512937 isoform X1
uncharacterized protein LOC123512937 isoform X4
uncharacterized protein LOC123512937 isoform X3
similar to RNA sequence (same species):INSD:GFFJ01062267.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 136 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 136 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
methyltransferase-like protein 22, transcript variant X1
methyltransferase-like protein 22, transcript variant X2
methyltransferase-like protein 22 isoform X1
methyltransferase-like protein 22 isoform X2
T-complex protein 11-like protein 1, transcript variant X2
T-complex protein 11-like protein 1, transcript variant X1
tumor protein p63-regulated gene 1-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein isoform X1
tumor protein p63-regulated gene 1-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
tumor protein p63-regulated gene 1-like protein isoform X2
tumor protein p63-regulated gene 1-like protein isoform X3
carbonic anhydrase-like, transcript variant X1
carbonic anhydrase-like, transcript variant X2
uncharacterized LOC123513039, transcript variant X1
uncharacterized LOC123513039, transcript variant X3
uncharacterized LOC123513039, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glucose dehydrogenase [FAD, quinone]-like
UPF0746 protein DDB_G0281095-like, transcript variant X2
UPF0746 protein DDB_G0281095-like, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X5
low-density lipoprotein receptor-like isoform X5
very low-density lipoprotein receptor-like, transcript variant X6
very low-density lipoprotein receptor-like, transcript variant X3
very low-density lipoprotein receptor-like, transcript variant X4
very low-density lipoprotein receptor-like, transcript variant X1
very low-density lipoprotein receptor-like, transcript variant X2
very low-density lipoprotein receptor-like, transcript variant X9
very low-density lipoprotein receptor-like, transcript variant X7
very low-density lipoprotein receptor-like, transcript variant X8
very low-density lipoprotein receptor-like isoform X3
low-density lipoprotein receptor-like isoform X1
very low-density lipoprotein receptor-like isoform X7
low-density lipoprotein receptor-like isoform X2
very low-density lipoprotein receptor-like isoform X8
low-density lipoprotein receptor-like isoform X4
very low-density lipoprotein receptor-like isoform X9
very low-density lipoprotein receptor-like isoform X6
uncharacterized LOC123513180, transcript variant X2
uncharacterized LOC123513180, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123513180, transcript variant X1
zwei Ig domain protein zig-8-like, transcript variant X2
zwei Ig domain protein zig-8-like, transcript variant X1
gamma-aminobutyric acid receptor-associated protein-like 1
ATPase family AAA domain-containing protein 5-like, transcript variant X3
ATPase family AAA domain-containing protein 5-like, transcript variant X4
ATPase family AAA domain-containing protein 5-like, transcript variant X1
ATPase family AAA domain-containing protein 5-like, transcript variant X2
ATPase family AAA domain-containing protein 5-like, transcript variant X5
ATPase family AAA domain-containing protein 5-like, transcript variant X6
ATPase family AAA domain-containing protein 5-like, transcript variant X7
ATPase family AAA domain-containing protein 5-like isoform X1
ATPase family AAA domain-containing protein 5-like isoform X2
ATPase family AAA domain-containing protein 5-like isoform X3
ATPase family AAA domain-containing protein 5-like isoform X4
dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123513283, transcript variant X1
uncharacterized LOC123513283, transcript variant X2
uncharacterized LOC123513282, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123513282, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123513282, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein THEM6-like, transcript variant X1
protein THEM6-like, transcript variant X2
transmembrane emp24 domain-containing protein 7-like
uncharacterized protein DDB_G0271670-like
discoidin domain-containing receptor 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: discoidin domain-containing receptor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable protein phosphatase 2C T23F11.1, transcript variant X2
probable protein phosphatase 2C T23F11.1, transcript variant X1
probable protein phosphatase 2C T23F11.1 isoform X1
probable protein phosphatase 2C T23F11.1 isoform X2
protoporphyrinogen oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
protoporphyrinogen oxidase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
protoporphyrinogen oxidase-like isoform X2
protoporphyrinogen oxidase-like isoform X1
coatomer subunit beta'-like, transcript variant X14
coatomer subunit beta'-like, transcript variant X10
coatomer subunit beta'-like, transcript variant X13
coatomer subunit beta'-like, transcript variant X9
coatomer subunit beta'-like, transcript variant X4
coatomer subunit beta'-like, transcript variant X6
coatomer subunit beta'-like, transcript variant X5
coatomer subunit beta'-like, transcript variant X3
coatomer subunit beta'-like, transcript variant X16
coatomer subunit beta'-like, transcript variant X15
coatomer subunit beta'-like, transcript variant X12
coatomer subunit beta'-like, transcript variant X11
coatomer subunit beta'-like, transcript variant X8
coatomer subunit beta'-like, transcript variant X7
coatomer subunit beta'-like, transcript variant X2
coatomer subunit beta'-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: piwi-like protein Siwi
b(0,+)-type amino acid transporter 1-like, transcript variant X2
b(0,+)-type amino acid transporter 1-like, transcript variant X6
b(0,+)-type amino acid transporter 1-like, transcript variant X1
b(0,+)-type amino acid transporter 1-like, transcript variant X3
b(0,+)-type amino acid transporter 1-like, transcript variant X8
b(0,+)-type amino acid transporter 1-like, transcript variant X7
b(0,+)-type amino acid transporter 1-like isoform X6
b(0,+)-type amino acid transporter 1-like isoform X7
b(0,+)-type amino acid transporter 1-like isoform X1
b(0,+)-type amino acid transporter 1-like isoform X2
b(0,+)-type amino acid transporter 1-like isoform X3
b(0,+)-type amino acid transporter 1-like isoform X8
b(0,+)-type amino acid transporter 1-like, transcript variant X5
b(0,+)-type amino acid transporter 1-like isoform X5
b(0,+)-type amino acid transporter 1-like, transcript variant X4
b(0,+)-type amino acid transporter 1-like isoform X4
U6 snRNA-associated Sm-like protein LSm1, transcript variant X4
U6 snRNA-associated Sm-like protein LSm1, transcript variant X3
U6 snRNA-associated Sm-like protein LSm1, transcript variant X2
U6 snRNA-associated Sm-like protein LSm1, transcript variant X1
U6 snRNA-associated Sm-like protein LSm1, transcript variant X6
U6 snRNA-associated Sm-like protein LSm1, transcript variant X5
U6 snRNA-associated Sm-like protein LSm1 isoform X1
U6 snRNA-associated Sm-like protein LSm1 isoform X2
U6 snRNA-associated Sm-like protein LSm1, transcript variant X7
U6 snRNA-associated Sm-like protein LSm1 isoform X3
zinc finger protein 236-like, transcript variant X2
zinc finger protein 236-like, transcript variant X1
LOW QUALITY PROTEIN: uncharacterized protein LOC123513080
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DCC-interacting protein 13-alpha-like, transcript variant X1
DCC-interacting protein 13-alpha-like, transcript variant X2
DCC-interacting protein 13-alpha-like isoform X1
DCC-interacting protein 13-alpha-like isoform X2
maternal effect protein staufen-like, transcript variant X5
maternal effect protein staufen-like, transcript variant X2
maternal effect protein staufen-like, transcript variant X1
maternal effect protein staufen-like, transcript variant X3
maternal effect protein staufen-like, transcript variant X4
maternal effect protein staufen-like isoform X5
maternal effect protein staufen-like isoform X4
maternal effect protein staufen-like isoform X2
maternal effect protein staufen-like isoform X1
maternal effect protein staufen-like isoform X3
uncharacterized LOC123513099, transcript variant X1
uncharacterized LOC123513099, transcript variant X2
uncharacterized LOC123513100, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123513100, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123513102, transcript variant X2
uncharacterized LOC123513102, transcript variant X1
hemicentin-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
hemicentin-2-like, transcript variant X2
uncharacterized LOC123513106, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123513106, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X7
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X5
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X1
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X2
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X4
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X3
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like, transcript variant X6
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit-like
LOW QUALITY PROTEIN: polyubiquitin-C-like
uncharacterized LOC123513111, transcript variant X2
uncharacterized LOC123513111, transcript variant X1
LOW QUALITY PROTEIN: zinc finger protein GLI2-like
mitochondrial import inner membrane translocase subunit Tim29-like
L-sorbose 1-dehydrogenase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
L-sorbose 1-dehydrogenase-like, transcript variant X1
NPC1-like intracellular cholesterol transporter 1, transcript variant X1
NPC1-like intracellular cholesterol transporter 1, transcript variant X2
NPC1-like intracellular cholesterol transporter 1
long-chain fatty acid transport protein 1-like, transcript variant X2
long-chain fatty acid transport protein 1-like, transcript variant X1
long-chain fatty acid transport protein 1-like, transcript variant X3
long-chain fatty acid transport protein 1-like
all trans-polyprenyl-diphosphate synthase PDSS2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
all trans-polyprenyl-diphosphate synthase PDSS2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
all trans-polyprenyl-diphosphate synthase PDSS2-like isoform X1
all trans-polyprenyl-diphosphate synthase PDSS2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
all trans-polyprenyl-diphosphate synthase PDSS2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
rho GTPase-activating protein 19-like, transcript variant X1
rho GTPase-activating protein 19-like, transcript variant X2
rho GTPase-activating protein 19-like, transcript variant X3
uncharacterized protein LOC123513115 isoform X1
rho GTPase-activating protein 19-like isoform X2
rho GTPase-activating protein 19-like isoform X3
protein phosphatase 1 regulatory subunit 21-like, transcript variant X2
protein phosphatase 1 regulatory subunit 21-like, transcript variant X1
protein phosphatase 1 regulatory subunit 21-like isoform X1
protein phosphatase 1 regulatory subunit 21-like isoform X2
iron-sulfur cluster assembly 2 homolog, mitochondrial-like, transcript variant X1
iron-sulfur cluster assembly 2 homolog, mitochondrial-like, transcript variant X2
iron-sulfur cluster assembly 2 homolog, mitochondrial-like isoform X2
iron-sulfur cluster assembly 2 homolog, mitochondrial-like isoform X1
protein kinase C-like, transcript variant X1
protein kinase C-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123513129, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC123513129, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123513130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123513130, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123513130, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC123513130 isoform X2
uncharacterized protein LOC123513130 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC123513131
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 8-like
glucose-fructose oxidoreductase domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucose-fructose oxidoreductase domain-containing protein 1-like, transcript variant X1
glucose-fructose oxidoreductase domain-containing protein 1-like, transcript variant X2
glucose-fructose oxidoreductase domain-containing protein 1-like isoform X3
glucose-fructose oxidoreductase domain-containing protein 1-like isoform X2
glucose-fructose oxidoreductase domain-containing protein 1-like isoform X1
uncharacterized LOC123513133, transcript variant X6
uncharacterized LOC123513133, transcript variant X5
uncharacterized LOC123513133, transcript variant X3
uncharacterized LOC123513133, transcript variant X1
uncharacterized LOC123513133, transcript variant X2
uncharacterized LOC123513133, transcript variant X4
uncharacterized protein LOC123513133 isoform X3
uncharacterized protein LOC123513133 isoform X2
uncharacterized protein LOC123513133 isoform X1
omega-amidase NIT2-like, transcript variant X3
omega-amidase NIT2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
omega-amidase NIT2-like, transcript variant X5
omega-amidase NIT2-like, transcript variant X2
omega-amidase NIT2-like, transcript variant X4
uncharacterized LOC123513139, transcript variant X4
uncharacterized LOC123513139, transcript variant X3
uncharacterized LOC123513139, transcript variant X2
uncharacterized LOC123513139, transcript variant X1
uncharacterized protein LOC123513139 isoform X2
uncharacterized protein LOC123513139 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
exonuclease 3'-5' domain-containing protein 2-like, transcript variant X2
exonuclease 3'-5' domain-containing protein 2-like, transcript variant X3
exonuclease 3'-5' domain-containing protein 2-like, transcript variant X1
exonuclease 3'-5' domain-containing protein 2-like isoform X1
exonuclease 3'-5' domain-containing protein 2-like isoform X2
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like isoform X1
chitooligosaccharidolytic beta-N-acetylglucosaminidase-like isoform X2
uncharacterized LOC123513146, transcript variant X3
uncharacterized LOC123513146, transcript variant X1
uncharacterized LOC123513146, transcript variant X2
uncharacterized protein LOC123513146 isoform X3
uncharacterized protein LOC123513146 isoform X2
uncharacterized protein LOC123513146 isoform X1
LOW QUALITY PROTEIN: DNA repair protein RAD50-like
uncharacterized LOC123512978, transcript variant X2
uncharacterized LOC123512978, transcript variant X1
uncharacterized LOC123512978, transcript variant X3
uncharacterized protein LOC123512978 isoform X1
uncharacterized protein LOC123512978 isoform X2
beta-secretase 1-like, transcript variant X1
beta-secretase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 8-like isoform X1
nucleoside diphosphate-linked moiety X motif 8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 8-like isoform X2
uncharacterized LOC123513052, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC123513052, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123513175, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123513175, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123513155, transcript variant X8
uncharacterized LOC123513154, transcript variant X1
uncharacterized LOC123513154, transcript variant X2
uncharacterized LOC123513154, transcript variant X3
uncharacterized LOC123513155, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123513155, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123513155, transcript variant X11
uncharacterized LOC123513155, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123513155, transcript variant X5
uncharacterized LOC123513155, transcript variant X2
uncharacterized LOC123513155, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123513155, transcript variant X4
uncharacterized LOC123513155, transcript variant X1
uncharacterized LOC123513155, transcript variant X3
uncharacterized protein LOC123513155 isoform X2
uncharacterized protein LOC123513155 isoform X4
uncharacterized protein LOC123513155 isoform X1
uncharacterized protein LOC123513155 isoform X3
uncharacterized LOC123513156, transcript variant X2
uncharacterized LOC123513156, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
carbohydrate sulfotransferase 11-like, transcript variant X2
carbohydrate sulfotransferase 11-like, transcript variant X1
carbohydrate sulfotransferase 11-like, transcript variant X3
carbohydrate sulfotransferase 11-like isoform X1
carbohydrate sulfotransferase 11-like isoform X3
carbohydrate sulfotransferase 11-like isoform X2
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
zwei Ig domain protein zig-8-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zwei Ig domain protein zig-8-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zwei Ig domain protein zig-8-like isoform X1
zwei Ig domain protein zig-8-like isoform X4
zwei Ig domain protein zig-8-like isoform X3
zwei Ig domain protein zig-8-like isoform X2
apolipophorins-like, transcript variant X1
apolipophorins-like, transcript variant X2
apolipophorins-like, transcript variant X3
uncharacterized protein LOC123513172 isoform X1
uncharacterized protein LOC123513172 isoform X2
uncharacterized LOC123513320, transcript variant X3
long-chain fatty acid transport protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
long-chain fatty acid transport protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
long-chain fatty acid transport protein 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
long-chain fatty acid transport protein 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
long-chain fatty acid transport protein 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
long-chain fatty acid transport protein 4-like isoform X1
long-chain fatty acid transport protein 4-like isoform X2
long-chain fatty acid transport protein 4-like isoform X3
uncharacterized LOC123513320, transcript variant X1
uncharacterized LOC123513320, transcript variant X2
tetratricopeptide repeat protein 30A-like, transcript variant X3
tetratricopeptide repeat protein 30A-like isoform X2
tetratricopeptide repeat protein 30A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetratricopeptide repeat protein 30A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tetratricopeptide repeat protein 30A-like isoform X1
uncharacterized LOC123513327, transcript variant X3
uncharacterized LOC123513327, transcript variant X1
uncharacterized LOC123513327, transcript variant X2
uncharacterized protein LOC123513327 isoform X1
uncharacterized protein LOC123513327 isoform X2
uncharacterized LOC123513327, transcript variant X4
uncharacterized protein LOC123513327 isoform X3
uncharacterized LOC123513327, transcript variant X5
uncharacterized protein LOC123513327 isoform X4
proteoglycan 4-like, transcript variant X1
proteoglycan 4-like, transcript variant X2
cyclin-dependent kinase inhibitor 1C-like
U8 snoRNA-decapping enzyme-like, transcript variant X2
U8 snoRNA-decapping enzyme-like, transcript variant X3
U8 snoRNA-decapping enzyme-like, transcript variant X4
U8 snoRNA-decapping enzyme-like, transcript variant X1
U8 snoRNA-decapping enzyme-like, transcript variant X6
U8 snoRNA-decapping enzyme-like, transcript variant X5
failed axon connections homolog, transcript variant X3
failed axon connections homolog, transcript variant X5
failed axon connections homolog, transcript variant X1
failed axon connections homolog, transcript variant X4
failed axon connections homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
serine/arginine repetitive matrix protein 2-like, transcript variant X1
serine/arginine repetitive matrix protein 2-like, transcript variant X2
serine/arginine repetitive matrix protein 2-like, transcript variant X6
serine/arginine repetitive matrix protein 2-like isoform X2
serine/arginine repetitive matrix protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC123513007 isoform X4
uncharacterized protein LOC123513007 isoform X3
serine/arginine repetitive matrix protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123513007 isoform X5
uncharacterized LOC123513011, transcript variant X2
uncharacterized LOC123513011, transcript variant X1
uncharacterized protein DDB_G0284459-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein DDB_G0284459-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein DDB_G0284459-like
uncharacterized LOC123513010, transcript variant X3
uncharacterized LOC123513010, transcript variant X1
uncharacterized LOC123513010, transcript variant X2
uncharacterized LOC123513008, transcript variant X3
uncharacterized LOC123513008, transcript variant X2
uncharacterized LOC123513008, transcript variant X1
uncharacterized LOC123513014, transcript variant X2
uncharacterized LOC123513014, transcript variant X1
uncharacterized LOC123513014, transcript variant X4
uncharacterized LOC123513014, transcript variant X5
uncharacterized LOC123513014, transcript variant X3
neural cell adhesion molecule 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
neural cell adhesion molecule 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
neural cell adhesion molecule 2-like, transcript variant X1
neural cell adhesion molecule 2-like isoform X2
uncharacterized LOC123513318, transcript variant X1
uncharacterized LOC123513318, transcript variant X2
uncharacterized LOC123513315, transcript variant X1
uncharacterized LOC123513315, transcript variant X2
uncharacterized protein LOC123513315 isoform X1
uncharacterized protein LOC123513315 isoform X2
uncharacterized LOC123513152, transcript variant X1
uncharacterized LOC123513152, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
uncharacterized LOC123513087, transcript variant X1
uncharacterized LOC123513087, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
cytoplasmic dynein 2 intermediate chain 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protein unc-80 homolog, transcript variant X1
protein unc-80 homolog, transcript variant X9
protein unc-80 homolog, transcript variant X11
protein unc-80 homolog, transcript variant X12
protein unc-80 homolog, transcript variant X13
protein unc-80 homolog, transcript variant X14
protein unc-80 homolog, transcript variant X15
protein unc-80 homolog, transcript variant X6
protein unc-80 homolog, transcript variant X3
protein unc-80 homolog, transcript variant X16
protein unc-80 homolog, transcript variant X10
protein unc-80 homolog, transcript variant X8
protein unc-80 homolog, transcript variant X4
protein unc-80 homolog, transcript variant X2
protein unc-80 homolog, transcript variant X5
protein unc-80 homolog, transcript variant X7
uncharacterized LOC123513184, transcript variant X1
uncharacterized LOC123513184, transcript variant X2
uncharacterized LOC123513184, transcript variant X3
uncharacterized protein LOC123513184 isoform X1
uncharacterized protein LOC123513184 isoform X2
RING finger and transmembrane domain-containing protein 2-like, transcript variant X4
zinc metalloproteinase nas-6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc metalloproteinase nas-6-like, transcript variant X1
zinc metalloproteinase nas-6-like isoform X2
zinc metalloproteinase nas-6-like isoform X1
RING finger and transmembrane domain-containing protein 2-like, transcript variant X6
RING finger and transmembrane domain-containing protein 2-like, transcript variant X5
RING finger and transmembrane domain-containing protein 2-like, transcript variant X1
RING finger and transmembrane domain-containing protein 2-like, transcript variant X2
RING finger and transmembrane domain-containing protein 2-like isoform X1
RING finger and transmembrane domain-containing protein 2-like, transcript variant X11
RING finger and transmembrane domain-containing protein 2-like, transcript variant X12
RING finger and transmembrane domain-containing protein 2-like, transcript variant X9
RING finger and transmembrane domain-containing protein 2-like, transcript variant X10
RING finger and transmembrane domain-containing protein 2-like, transcript variant X3
RING finger and transmembrane domain-containing protein 2-like isoform X2
RING finger and transmembrane domain-containing protein 2-like, transcript variant X8
RING finger and transmembrane domain-containing protein 2-like, transcript variant X7
RING finger and transmembrane domain-containing protein 2-like, transcript variant X13
RING finger and transmembrane domain-containing protein 2-like isoform X3
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X3
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X4
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X1
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X5
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X2
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X6
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X7
FYVE and coiled-coil domain-containing protein 1-like, transcript variant X8
FYVE and coiled-coil domain-containing protein 1-like isoform X3
FYVE and coiled-coil domain-containing protein 1-like isoform X1
FYVE and coiled-coil domain-containing protein 1-like isoform X4
FYVE and coiled-coil domain-containing protein 1-like isoform X5
FYVE and coiled-coil domain-containing protein 1-like isoform X2
scavenger receptor class B member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X2
sodium- and chloride-dependent GABA transporter 1-like, transcript variant X1
sodium- and chloride-dependent GABA transporter 1-like
prolyl 4-hydroxylase subunit alpha-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 7 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123513340, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123513340, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123513340, transcript variant X1
uncharacterized protein LOC123513340 isoform X2
uncharacterized protein LOC123513340 isoform X1
uncharacterized protein LOC123513340 isoform X3
uncharacterized LOC123513340, transcript variant X4
histone-lysine N-methyltransferase 2D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha-like, transcript variant X1
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha-like, transcript variant X2
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha-like isoform X2
phosphatidylinositol 5-phosphate 4-kinase type-2 alpha-like isoform X1
ADP-ribosylation factor-like protein 3, transcript variant X2
ADP-ribosylation factor-like protein 3, transcript variant X1
zinc finger homeobox protein 3-like, transcript variant X2
zinc finger homeobox protein 3-like, transcript variant X3
zinc finger homeobox protein 3-like, transcript variant X1
zinc finger homeobox protein 3-like, transcript variant X4
zinc finger homeobox protein 3-like, transcript variant X5
zinc finger homeobox protein 3-like, transcript variant X6
zinc finger homeobox protein 3-like, transcript variant X7
zinc finger homeobox protein 3-like isoform X1
zinc finger homeobox protein 3-like isoform X2
zinc finger homeobox protein 3-like isoform X3
zinc finger homeobox protein 3-like isoform X4
zinc finger homeobox protein 3-like isoform X5
protein-L-histidine N-pros-methyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein-L-histidine N-pros-methyltransferase-like isoform X2
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein-L-histidine N-pros-methyltransferase-like, transcript variant X1
protein-L-histidine N-pros-methyltransferase-like isoform X1
Hermansky-Pudlak syndrome 3 protein-like
LOW QUALITY PROTEIN: Hermansky-Pudlak syndrome 3 protein-like
dnaJ homolog subfamily C member 13-like, transcript variant X6
dnaJ homolog subfamily C member 13-like, transcript variant X5
dnaJ homolog subfamily C member 13-like, transcript variant X4
dnaJ homolog subfamily C member 13-like, transcript variant X1
dnaJ homolog subfamily C member 13-like, transcript variant X3
dnaJ homolog subfamily C member 13-like, transcript variant X2
dnaJ homolog subfamily C member 13-like isoform X4
dnaJ homolog subfamily C member 13-like isoform X3
dnaJ homolog subfamily C member 13-like isoform X2
dnaJ homolog subfamily C member 13-like isoform X1
hepatoma-derived growth factor-related protein 2-like, transcript variant X5
hepatoma-derived growth factor-related protein 2-like isoform X5
hepatoma-derived growth factor-related protein 2-like, transcript variant X3
hepatoma-derived growth factor-related protein 2-like, transcript variant X2
hepatoma-derived growth factor-related protein 2-like, transcript variant X1
hepatoma-derived growth factor-related protein 2-like, transcript variant X7
hepatoma-derived growth factor-related protein 2-like isoform X2
hepatoma-derived growth factor-related protein 2-like isoform X3
hepatoma-derived growth factor-related protein 2-like isoform X1
hepatoma-derived growth factor-related protein 2-like, transcript variant X4
hepatoma-derived growth factor-related protein 2-like isoform X4
hepatoma-derived growth factor-related protein 2-like isoform X7
hepatoma-derived growth factor-related protein 2-like, transcript variant X6
hepatoma-derived growth factor-related protein 2-like isoform X6
uncharacterized LOC123513208, transcript variant X2
uncharacterized LOC123513208, transcript variant X1
uncharacterized protein LOC123513208 isoform X2
uncharacterized protein LOC123513208 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
translin-associated protein X-like, transcript variant X2
translin-associated protein X-like, transcript variant X1
translin-associated protein X-like, transcript variant X3
translin-associated protein X-like, transcript variant X4
alkaline phosphatase-like, transcript variant X4
alkaline phosphatase-like, transcript variant X3
alkaline phosphatase-like, transcript variant X2
alkaline phosphatase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
glutathione synthetase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
glutathione synthetase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
glutathione synthetase-like, transcript variant X4
glutathione synthetase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X26
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X28
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X29
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X41
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X30
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X36
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X46
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X27
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X49
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X50
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X47
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X48
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X15
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X19
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X22
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X11
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X16
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X45
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X39
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X20
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X18
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X14
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X23
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X44
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X13
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X17
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X21
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X42
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X43
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X12
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X25
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X40
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X33
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X34
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X32
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X35
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X38
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X24
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X37
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X31
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X25
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X27
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X28
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X40
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X29
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X35
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X45
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X26
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X48
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X49
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X46
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X8
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X14
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X18
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X21
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X10
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X15
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X44
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X38
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X19
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X17
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X13
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X22
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X43
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X12
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X16
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X20
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X41
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X42
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X11
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X24
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X39
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X32
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X33
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X31
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X34
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X37
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X23
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X36
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X30
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X47
Down syndrome cell adhesion molecule-like protein Dscam2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like isoform X1
uncharacterized protein LOC123513219 isoform X2
cation-dependent mannose-6-phosphate receptor-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor-like isoform X3
zinc finger and BTB domain-containing protein 11-like, transcript variant X1
zinc finger and BTB domain-containing protein 11-like, transcript variant X2
zinc finger and BTB domain-containing protein 11-like, transcript variant X3
zinc finger and BTB domain-containing protein 11-like
E3 ubiquitin-protein ligase hyd-like, transcript variant X2
E3 ubiquitin-protein ligase hyd-like, transcript variant X1
E3 ubiquitin-protein ligase hyd-like isoform X1
E3 ubiquitin-protein ligase hyd-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thyroid receptor-interacting protein 11-like, transcript variant X2
thyroid receptor-interacting protein 11-like, transcript variant X1
thyroid receptor-interacting protein 11-like, transcript variant X3
thyroid receptor-interacting protein 11-like isoform X3
thyroid receptor-interacting protein 11-like isoform X2
thyroid receptor-interacting protein 11-like isoform X1
synaptic vesicle membrane protein VAT-1 homolog-like
secretory carrier-associated membrane protein 1-like, transcript variant X4
secretory carrier-associated membrane protein 1-like, transcript variant X9
secretory carrier-associated membrane protein 1-like, transcript variant X8
secretory carrier-associated membrane protein 1-like, transcript variant X6
secretory carrier-associated membrane protein 1-like, transcript variant X7
secretory carrier-associated membrane protein 1-like, transcript variant X5
secretory carrier-associated membrane protein 1-like, transcript variant X3
secretory carrier-associated membrane protein 1-like, transcript variant X2
secretory carrier-associated membrane protein 1-like, transcript variant X1
secretory carrier-associated membrane protein 1-like isoform X3
secretory carrier-associated membrane protein 1-like isoform X6
secretory carrier-associated membrane protein 1-like isoform X4
secretory carrier-associated membrane protein 1-like isoform X5
secretory carrier-associated membrane protein 1-like isoform X2
secretory carrier-associated membrane protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcription factor HES-2-like, transcript variant X1
transcription factor HES-2-like, transcript variant X2
enhancer of split mgamma protein-like isoform X1
transcription factor HES-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
uncharacterized LOC123513248, transcript variant X2
uncharacterized LOC123513248, transcript variant X1
uncharacterized LOC123513248, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC123513232, transcript variant X2
uncharacterized LOC123513232, transcript variant X1
uncharacterized protein LOC123513232 isoform X1
uncharacterized protein LOC123513232 isoform X2
vesicle transport protein GOT1B-like, transcript variant X1
vesicle transport protein GOT1B-like, transcript variant X2
vesicle transport protein GOT1B-like isoform X1
vesicle transport protein GOT1B-like isoform X2
succinate dehydrogenase cytochrome b560 subunit, mitochondrial-like
uncharacterized LOC123512922, transcript variant X4
uncharacterized LOC123512922, transcript variant X1
uncharacterized LOC123512922, transcript variant X5
uncharacterized LOC123512922, transcript variant X2
uncharacterized LOC123512922, transcript variant X3
uncharacterized LOC123512922, transcript variant X6
uncharacterized LOC123512922, transcript variant X7
uncharacterized LOC123512922, transcript variant X8
uncharacterized protein LOC123512922 isoform X1
uncharacterized protein LOC123512922 isoform X4
uncharacterized protein LOC123512922 isoform X5
uncharacterized protein LOC123512922 isoform X8
uncharacterized protein LOC123512922 isoform X2
uncharacterized protein LOC123512922 isoform X3
uncharacterized protein LOC123512922 isoform X6
uncharacterized protein LOC123512922 isoform X7
LOW QUALITY PROTEIN: protein PRRC2A-like
eukaryotic initiation factor 4A-I-like, transcript variant X1
eukaryotic initiation factor 4A-I-like, transcript variant X2
eukaryotic initiation factor 4A-I-like, transcript variant X4
eukaryotic initiation factor 4A-I-like, transcript variant X3
eukaryotic initiation factor 4A-I-like isoform X1
eukaryotic initiation factor 4A-I-like isoform X2
eukaryotic initiation factor 4A-I-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123513026, transcript variant X1
uncharacterized LOC123513026, transcript variant X2
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123513191, transcript variant X1
uncharacterized LOC123513191, transcript variant X2
uncharacterized LOC123513191, transcript variant X3
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
actinia tenebrosa protease inhibitors-like
RNA-binding protein 34-like, transcript variant X2
RNA-binding protein 34-like, transcript variant X3
RNA-binding protein 34-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
collagen alpha-2(IV) chain-like, transcript variant X1
collagen alpha-2(IV) chain-like, transcript variant X2
collagen alpha-2(IV) chain-like isoform X1
collagen alpha-2(IV) chain-like isoform X2
alpha-1,3/1,6-mannosyltransferase ALG2-like, transcript variant X3
alpha-1,3/1,6-mannosyltransferase ALG2-like, transcript variant X2
alpha-1,3/1,6-mannosyltransferase ALG2-like, transcript variant X1
alpha-1,3/1,6-mannosyltransferase ALG2-like isoform X3
alpha-1,3/1,6-mannosyltransferase ALG2-like isoform X2
alpha-1,3/1,6-mannosyltransferase ALG2-like isoform X1
mediator of DNA damage checkpoint protein 1-like
nuclear hormone receptor HR96-like, transcript variant X3
nuclear hormone receptor HR96-like, transcript variant X1
nuclear hormone receptor HR96-like, transcript variant X2
nuclear hormone receptor HR96-like, transcript variant X4
thyroid hormone receptor alpha-like isoform X2
nuclear hormone receptor HR96-like isoform X1
nuclear hormone receptor HR96-like isoform X3
probable chitinase 2, transcript variant X4
probable chitinase 2, transcript variant X5
probable chitinase 2, transcript variant X3
probable chitinase 2, transcript variant X2
probable chitinase 2, transcript variant X1
CENPB DNA-binding domain-containing protein 1-like
uncharacterized LOC123513302, transcript variant X5
uncharacterized LOC123513302, transcript variant X4
uncharacterized protein LOC123513302 isoform X2
uncharacterized LOC123513302, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123513302, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123513302, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC123513302 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 22 member 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 22 member 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 22 member 7-like isoform X1
solute carrier family 22 member 7-like isoform X3
solute carrier family 22 member 7-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 22 member 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
solute carrier family 22 member 7-like isoform X2
solute carrier family 22 member 7-like isoform X4
carcinine transporter-like, transcript variant X1
carcinine transporter-like, transcript variant X2
solute carrier family 22 member 15-like isoform X2
oxalate:formate antiporter-like, transcript variant X7
oxalate:formate antiporter-like, transcript variant X10
oxalate:formate antiporter-like, transcript variant X5
oxalate:formate antiporter-like isoform X7
uncharacterized MFS-type transporter YhjX-like isoform X10
uncharacterized MFS-type transporter YhjX-like isoform X5
oxalate:formate antiporter-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized MFS-type transporter YhjX-like isoform X6
oxalate:formate antiporter-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X2
oxalate:formate antiporter-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 long SRA reads, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
oxalate:formate antiporter-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized protein LOC123513306 isoform X9
oxalate:formate antiporter-like isoform X3
uncharacterized MFS-type transporter YhjX-like isoform X2
uncharacterized MFS-type transporter YhjX-like isoform X8
uncharacterized MFS-type transporter YhjX-like isoform X1
uncharacterized MFS-type transporter YhjX-like isoform X4
oxalate:formate antiporter-like isoform X12
mpv17-like protein 2, transcript variant X8
mpv17-like protein 2, transcript variant X2
mpv17-like protein 2, transcript variant X1
mpv17-like protein 2, transcript variant X7
mpv17-like protein 2, transcript variant X5
mpv17-like protein 2, transcript variant X3
mpv17-like protein 2, transcript variant X4
mpv17-like protein 2, transcript variant X9
mpv17-like protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments